Overview

Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder

Status:
Active, not recruiting

Trial end date:
2022-03-01

Target enrollment:
0

Participant gender:
All

Summary

Percutaneous Interruption of the Coracohumeral Ligament for the treatment of Frozen Shoulder.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Albert Einstein College of Medicine

Treatments:

Anesthetics
Anesthetics, Local

Criteria

Inclusion Criteria:

- Established Diagnosis of Adhesive capsulitis (AC) Ligament Flavum >3mm, diagnosed by
US evaluation decreased shoulder ROM in external rotation and abduction (50% of
unaffected side)

- Patients who have tried other conventional therapies like steroid treatments, surgical
treatments, physiotherapy with little (defined by less than 20 degrees improvement in
shoulder ROM - external rotation) to no improvement in the shoulder ROM

Exclusion Criteria:

- Age less than 18 years and greater than 89 years

- Patients with AC but showing improvement in shoulder ROM progressively (defined by
improvement in ROM > 200 external rotation or 20 degrees per week when undergoing
physiotherapy)

- Patients who are currently pregnant